======= DEPDC5 ======= == Gene Information == * **Official Symbol**: DEPDC5 * **Official Name**: DEP domain containing 5, GATOR1 subcomplex subunit * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9681|9681]] * **UniProt**: [[https://www.uniprot.org/uniprot/O75140|O75140]] * **Interactions**: [[https://thebiogrid.org/search.php?search=DEPDC5&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20DEPDC5|Open PubMed]] * **OMIM**: [[https://omim.org/entry/614191|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the IML1 family of proteins involved in G-protein signaling pathways. The mechanistic target of rapamycin complex 1 (mTORC1) pathway regulates cell growth by sensing the availability of nutrients. The protein encoded by this gene is a component of the GATOR1 (GAP activity toward Rags) complex which inhibits the amino acid-sensing branch of the mTORC1 pathway. Mutations in this gene are associated with autosomal dominant familial focal epilepsy with variable foci. A single nucleotide polymorphism in an intron of this gene has been associated with an increased risk of hepatocellular carcinoma in individuals with chronic hepatitis C virus infection. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]. * **UniProt Summary**: As a component of the GATOR1 complex functions as an inhibitor of the amino acid-sensing branch of the TORC1 pathway. The GATOR1 complex strongly increases GTP hydrolysis by RRAGA and RRAGB within RRAGC-containing heterodimers, thereby deactivating RRAGs, releasing mTORC1 from lysosomal surface and inhibiting mTORC1 signaling. The GATOR1 complex is negatively regulated by GATOR2 the other GATOR subcomplex in this amino acid-sensing branch of the TORC1 pathway. {ECO:0000269|PubMed:23723238, ECO:0000269|PubMed:25457612}. |DEP| |DUF3608| |GATOR1 complex| |negative regulation of TORC1 signaling| |Cul3-RING ubiquitin ligase complex| |regulation of TORC1 signaling| |cellular response to amino acid starvation| |response to amino acid starvation| |negative regulation of TOR signaling| |regulation of TOR signaling| |cellular response to starvation| |response to starvation| |cellular response to nutrient levels| |lysosome| |cellular response to extracellular stimulus| |protein-containing complex binding| |GTPase activator activity| |lysosomal membrane| |cellular response to external stimulus| |positive regulation of GTPase activity| |regulation of GTPase activity| |response to nutrient levels| |negative regulation of intracellular signal transduction| |response to extracellular stimulus| |perinuclear region of cytoplasm| |positive regulation of hydrolase activity| |negative regulation of signal transduction| |regulation of hydrolase activity| |negative regulation of cell communication| |negative regulation of signaling| |positive regulation of catalytic activity| |negative regulation of response to stimulus| |intracellular signal transduction| |cellular response to stress| |positive regulation of molecular function| |regulation of intracellular signal transduction| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp499|LY2090314 0.003μM R08 exp499]]|-3.9| |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|-3.59| |[[:results:exp84|UM0125461 0.74μM R02 exp84]]|-3.4| |[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|-3.11| |[[:results:exp436|Dynasore 7μM R08 exp436]]|-2.91| |[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|-2.89| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|-2.85| |[[:results:exp180|Dynasore 10μM R04 exp180]]|-2.71| |[[:results:exp223|Cabazitaxel 0.001μM R05 exp223]]|-2.69| |[[:results:exp67|BVD-523 15μM R02 exp67]]|-2.62| |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|-2.6| |[[:results:exp416|Tubacin 1.6μM R07 exp416]]|-2.58| |[[:results:exp122|Golgicide-A 4μM R03 exp122]]|-2.44| |[[:results:exp450|Artemisinin 50μM R08 exp450]]|-2.42| |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-2.38| |[[:results:exp525|Sulforaphane 9μM R08 exp525]]|-2.27| |[[:results:exp464|Calcipotriol 5μM R08 exp464]]|-2.26| |[[:results:exp517|Quercetin 20μM R08 exp517]]|-2.25| |[[:results:exp299|Talazoparib 0.006μM R06 exp299]]|-2.25| |[[:results:exp445|∆-9-Tetrahydrocannabinol 30μM R08 exp445]]|-2.23| |[[:results:exp515|PU-H71 1μM R08 exp515]]|-2.21| |[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|-2.2| |[[:results:exp356|Docosahexaenoic-acid 50μM R07 exp356]]|-2.19| |[[:results:exp81|Selumetinib 20μM R02 exp81]]|-2.16| |[[:results:exp472|CI-1040 9.5μM R08 exp472]]|-2.16| |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|-2.1| |[[:results:exp184|Ixabepilone 0.004 to 0.005μM on day4 R04 exp184]]|-2.05| |[[:results:exp5|Alpha-Amanitin 0.5μM R00 exp5]]|-2.03| |[[:results:exp231|Epothilone-B 0.0015μM R05 exp231]]|-2.03| |[[:results:exp535|Trimetrexate 0.03μM R08 exp535]]|-2.02| |[[:results:exp59|UMK57 1μM R01 exp59]]|-2.02| |[[:results:exp78|Pterostilbene 16μM R02 exp78]]|-2| |[[:results:exp357|Dorsomorphin 5μM R07 exp357]]|-1.99| |[[:results:exp159|Docetaxel 0.001 to 0.002μM on day4 R04 exp159]]|-1.98| |[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|-1.98| |[[:results:exp60|Vinblastine 0.002μM R01 exp60]]|-1.98| |[[:results:exp460|BML-284 0.09μM R08 exp460]]|-1.96| |[[:results:exp346|CoCl2 18μM R07 exp346]]|-1.96| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|-1.95| |[[:results:exp164|Q15 1 to 2μM on day4 R04 exp164]]|-1.94| |[[:results:exp64|Nocodazole 0.2μM R02 exp64]]|-1.92| |[[:results:exp177|Apcin 25μM plus proTAME 2μM R04 exp177]]|-1.91| |[[:results:exp526|Sulforaphane 9μM R08 exp526 no dilution day6]]|-1.91| |[[:results:exp354|Diepoxybutane 3μM R07 exp354]]|-1.89| |[[:results:exp198|Etoposide 0.1μM R05 exp198]]|-1.87| |[[:results:exp230|Epigallocatechin gallate 20μM R05 exp230]]|-1.86| |[[:results:exp249|Vinorelbine 0.001μM R05 exp249]]|-1.86| |[[:results:exp466|Cannabidiol 20μM R08 exp466]]|-1.84| |[[:results:exp275|Citral 75μM R06 exp275]]|-1.83| |[[:results:exp329|Hydroxyurea 100μM R07 exp329]]|-1.83| |[[:results:exp520|Rucaparib 6.5μM R08 exp520]]|-1.82| |[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|-1.76| |[[:results:exp286|HMS-I2 1μM R06 exp286]]|-1.74| |[[:results:exp289|Hydroxyurea 15μM R06 exp289]]|-1.74| |[[:results:exp399|Salubrinal 20μM R07 exp399]]|-1.74| |[[:results:exp73|LJH685 5μM R02 exp73]]|-1.73| |[[:results:exp32|Rifampicin 10μM R00 exp32]]|-1.73| |[[:results:exp456|Benzoate 20000μM R08 exp456]]|-1.72| |[[:results:exp287|HMS-I2 5μM R06 exp287]]|-1.72| |[[:results:exp468|CB-5083 0.4μM R08 exp468]]|-1.7| |[[:results:exp534|Trientine 500μM R08 exp534]]|1.71| |[[:results:exp124|GSK343 3μM R03 exp124]]|1.75| |[[:results:exp465|Cannabidiol 13μM R08 exp465]]|1.79| |[[:results:exp470|Chloroquine 32μM R08 exp470]]|1.8| |[[:results:exp218|A-395 10μM R05 exp218]]|1.94| |[[:results:exp382|Palbociclib 1μM R07 exp382]]|2.01| |[[:results:exp363|GSK-J4 1-1.25μM to day4 R07 exp363]]|2.05| |[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|2.09| |[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|2.13| |[[:results:exp414|Tozasertib 0.1μM R07 exp414]]|2.13| |[[:results:exp506|Momordin-Ic 10μM R08 exp506]]|2.16| |[[:results:exp301|VER-155008 3.9μM R06 exp301]]|2.26| |[[:results:exp352|Dexamethasone 0.006 to 0.015μM on day4 R07 exp352]]|2.57| |[[:results:exp233|EPZ-5676 30μM R05 exp233]]|2.59| |[[:results:exp389|PF-06409577 20μM R07 exp389]]|2.88| |[[:results:exp452|Azithromycin 100μM R08 exp452]]|3.12| |[[:results:exp216|Erlotinib 10μM R05 exp216]]|3.56| |[[:results:exp151|SGC0946 7μM R03 exp151]]|3.57| |[[:results:exp485|GSK626616 14μM R08 exp485]]|4.56| |[[:results:exp504|MK2206 4μM R08 exp504]]|6.01| ^Gene^Correlation^ |[[:human genes:n:nprl3|NPRL3]]|0.839| |[[:human genes:n:nprl2|NPRL2]]|0.808| |[[:human genes:s:szt2|SZT2]]|0.784| |[[:human genes:k:kptn|KPTN]]|0.714| |[[:human genes:i:itfg2|ITFG2]]|0.664| |[[:human genes:c:c12orf66|C12orf66]]|0.65| |[[:human genes:t:tsc2|TSC2]]|0.628| |[[:human genes:s:sesn2|SESN2]]|0.598| |[[:human genes:t:tsc1|TSC1]]|0.573| |[[:human genes:a:anp32a|ANP32A]]|0.454| |[[:human genes:c:ccdc130|CCDC130]]|0.454| |[[:human genes:z:zfp36l2|ZFP36L2]]|0.44| |[[:human genes:c:cnot2|CNOT2]]|0.402| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 9249 * **Expression level (log2 read counts)**: 5.36 {{:chemogenomics:nalm6 dist.png?nolink |}}